# BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE
> **ANDA206953** · Abbreviated New Drug Application (Generic) · Sponsor: DR REDDYS LABS SA · Approved 2020-07-17
## Drug
- **FDA Application Number:** ANDA206953
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE
- **Generic name:** Buprenorphine Hydrochloride
- **Active ingredients:** BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE
- **Dosage form:** TABLET
- **Route:** SUBLINGUAL
- **Marketing status:** Discontinued
- **Sponsor:** DR REDDYS LABS SA
- **First approval:** 2020-07-17
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206953)
---
*AI Analytics · CC0 1.0*